A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Dementia with Lewy Bodies (DLB)
J
Jared Brosch, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to evaluate the long-term safety and tolerability of 35 mg and 70 mg RVT-101 in subjects with Dementia with Lewy Bodies (DLB) who have participated in the lead0in study RVT-101-2001 (IRB# 1603122491).
Description
The purpose of this study is to evaluate the long-term safety and tolerability of 35 mg and 70 mg RVT-101 in subjects with Dementia with Lewy Bodies (DLB) who have participated in the lead0in study RVT-101-2001 (IRB# 1603122491).
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
dementia,Lewy bodies
-
Age: - 100 Years
-
Gender: All
Updated on
25 Apr 2024.
Study ID: 1608864352
